Tag Archives: drug labeling

FDA: Lower Ambien’s Dose to Prevent Drowsy Driving

Posted on May 20, 2013 by Finkelstein & Partners

On Wednesday, May 15, The FDA approved a new, lower-dose labeling for the popular sleep drug, Ambien, in an effort to decrease daytime drowsiness that could potentially be a danger while performing certain tasks such as driving. In January, drugs … Continue reading →

Posted in Dangerous Drugs, Drowsy Driving | Tagged , , | Leave a comment

U.S. Supreme Court to Decide Whether Victims Can Sue Generic Drugmakers For Inadequate Labeling

Posted on December 13, 2010 by Kenneth Fromson, Esq.

Drug companies who manufacture and sell generic drugs reap the profits from selling the bioequivalent versions of their counterpart brand name drugs; but they want to avoid responsibility when a victim of their generic drug seeks compensation for a side … Continue reading →

Posted in Dangerous Drugs | Tagged , , , , , , , , , , | Leave a comment